MedTrace Logo

A Study of the Experience of Music Therapy in Cancer Patients With Delirium

NCT04104217 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2023-08-22

No results posted yet for this study

Summary

The purpose of this study is to improve our understanding of the experience of music therapy by cancer patients with delirium, and the experience of music therapists working with these patients. The researchers are focusing on patients with delirium because of the challenging symptoms of this condition.

At MSK, music therapy is routinely used in patients with cancer. Music therapy sessions are done at the patient's bedside, where the music therapist plays live music on a guitar, keyboard, harp, or percussion instrument, sometimes as accompaniment to singing.

Conditions

  • Cancer Patients With Delirium

Interventions

BEHAVIORAL

Music therapy

Music therapy sessions may last 20-60 minutes, with length and frequency to be determined mutually (generally 1-3 times per week). Music therapy sessions are done at the patient's bedside, where the music therapist plays live music on a guitar, keyboard, harp, or percussion instrument, sometimes as accompaniment to singing.

BEHAVIORAL

Interviews

Each interview will be conducted in person in a private setting (with the exception of caregivers, who have the option to conduct interviews over the phone if it is not feasible to take place in the hospital). Each interview will follow a semi-structured interview guide and will ask for consent to audio record the interviews .

Sponsors & Collaborators

Principal Investigators

  • Holly Mentzer, MA, LCAT, MT-BC · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-23
Primary Completion
2023-08-18
Completion
2023-08-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04104217 on ClinicalTrials.gov